NCT05003544

Brief Summary

90 patients ASA I-III, undergoing Total hip arthroplasty (THA) under spinal anesthesia, will be randomly assigned into one of three groups, namely group A (n=30), where an PENG block, group B (N:30) where an inra-articuler, and group C (n=30) where Quadratus lumborum block will be performed preoperatively. All patients will receive a standardized postoperative analgesia regimen. NRS scores will be evaluated in static and dynamic conditions during the first 48 hours postoperatively.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
89

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 3, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 12, 2021

Completed
13 days until next milestone

Study Start

First participant enrolled

August 25, 2021

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 8, 2022

Completed
12 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2022

Completed
Last Updated

January 31, 2023

Status Verified

September 1, 2022

Enrollment Period

1.3 years

First QC Date

August 3, 2021

Last Update Submit

January 28, 2023

Conditions

Keywords

PENG blockintra-artikulerQuadrotus lumborum blockHip Arthropathy

Outcome Measures

Primary Outcomes (1)

  • Numerical Rating Scale (NRS) scores

    Range 0-10, 0=no pain, 10=the worse pain ever

    48 Hours

Secondary Outcomes (8)

  • Opioid consumption

    3-6-8-12-24 and 48 hours

  • Static and dynamic pain

    3-6-8-12-24 and 48 hours

  • Presence of quadriceps motor block (defined as paralysis or paresis )

    3-6-12-24 hours after the block

  • Hip adduction strength

    3-6-12-24 hours after the block

  • Presence of postoperative nausea, vomiting, pruritus, urinary retention, respiratory depression

    3-6-12-24 hours after the block

  • +3 more secondary outcomes

Study Arms (3)

PENG BLOCK ( Group A)

ACTIVE COMPARATOR

A regional block will be applied while the patient is in the supine position. A curvilinear low-frequency ultrasound probe (2-5MHz) will initially be placed in a transverse plane on the AIIS and then rotate the probe approximately 45 degrees counterclockwise to align with the pubic ramus. In this view, IPE, iliopsoas muscle and tendon, femoral artery and pectineus muscle will be observed. A 22 gauge, 80 mm needle will be inserted from lateral to medial in an in-plane approach to place the psoas tendon anteriorly and posteriorly in the musculofacial plane between the pubic ramus. Following negative aspiration, a local anesthetic solution (20ml bupivacaine 0.5%) will be injected.

Procedure: Group A

Intra-articular( Group B)

ACTIVE COMPARATOR

It will be applied to the intra-articular region by the surgeon at the end of the operation. A volume of 60 ml (30 ml of 0.5% bupivacaine and 30 ml of 0.9% NaCl)

Procedure: Group B

Quadratus lumborum block ( Group C)

ACTIVE COMPARATOR

The patient will be in the lateral position. A low-frequency convex probe will be vertically attached above the iliac crest and a needle will be inserted in-plane from the posterior edge of the convex probe through the quadratus lumborum in an anteromedial direction. The needle tip will be placed between the psoas major muscle and the quadratus lumborum muscle. After negative aspiration, 30 mL of 0.5 % of bupivacaine will be injected into the fascial plane incrementally, aspirating every 5 ml.

Procedure: Group C

Interventions

Group APROCEDURE

PENG BLOCK

PENG BLOCK ( Group A)
Group BPROCEDURE

Intra-articular

Intra-articular( Group B)
Group CPROCEDURE

Quadratus lumborum block

Quadratus lumborum block ( Group C)

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Physical status according to American Society of Anesthesiologists (ASA ) I-III

You may not qualify if:

  • Previous operation on the same hip
  • Hepatic or renal insufficiency
  • Younger than 18 years old and older than 85
  • Patients undergoing general anesthesia
  • Allergy or intolerance to one of the study medications
  • BMI \>40
  • ASA IV
  • Chronic gabapentin/pregabalin use ( regular use for longer than 3 months)
  • Chronic opioid use ( taking opioids for longer than 3 months, or daily oral morphine equivalent of \>5 mg/day one month

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tayfun Et

Karaman, 70200, Turkey (Türkiye)

Location

Related Publications (1)

  • Adhikary SD, Short AJ, El-Boghdadly K, Abdelmalak MJ, Chin KJ. Transmuscular quadratus lumborum versus lumbar plexus block for total hip arthroplasty: A retrospective propensity score matched cohort study. J Anaesthesiol Clin Pharmacol. 2018 Jul-Sep;34(3):372-378. doi: 10.4103/joacp.JOACP_335_17.

    PMID: 30386022BACKGROUND

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 3, 2021

First Posted

August 12, 2021

Study Start

August 25, 2021

Primary Completion

December 8, 2022

Study Completion

December 20, 2022

Last Updated

January 31, 2023

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations